ClearPoint Neuro, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ClearPoint Neuro, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • ClearPoint Neuro, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $35.8M, a 18.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $35.8M +$5.66M +18.8% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $30.2M +$832K +2.84% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $29.3M +$4.87M +19.9% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $24.5M +$714K +3.01% Dec 31, 2020 10-K 2022-03-09
Q4 2019 $23.7M +$1.27M +5.67% Dec 31, 2019 10-K 2021-03-22
Q4 2018 $22.5M +$2.76M +14% Dec 31, 2018 10-K 2020-03-27
Q4 2017 $19.7M -$14.9M -43.1% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $34.6M +$3.46M +11.1% Dec 31, 2016 10-K 2018-03-21
Q4 2015 $31.2M +$4.98M +19% Dec 31, 2015 10-K 2017-03-09
Q4 2014 $26.2M +$51.2M Dec 31, 2014 10-K 2016-03-25
Q4 2013 -$25M -$46.9M -214% Dec 31, 2013 10-K 2015-03-17
Q4 2012 $21.9M +$191K +0.88% Dec 31, 2012 10-K 2014-03-28
Q4 2011 $21.7M Dec 31, 2011 10-K/A 2013-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.